Daniel A Pollyea Selected Research

Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))

10/2020	New directions for emerging therapies in acute myeloid leukemia: the next chapter.
6/2018	Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
10/2017	Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel A Pollyea Research Topics

Disease

69	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 11/2010
20	Leukemia 01/2023 - 05/2013
12	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 12/2017
11	Neoplasms (Cancer) 01/2023 - 03/2004
7	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2017
5	Disease Progression 01/2023 - 04/2013
4	B-Cell Lymphoma (Lymphoma, B Cell) 10/2020 - 01/2018
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2023 - 09/2014
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 09/2014
3	Thrombocytopenia (Thrombopenia) 01/2023 - 01/2015
3	Anemia 12/2022 - 01/2015
3	Cytopenia 01/2021 - 01/2015
2	Pneumonia (Pneumonitis) 12/2022 - 01/2019
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 09/2023
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2023
1	Multiple Myeloma 01/2023
1	Hematologic Diseases (Blood Diseases) 01/2023
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023
1	Febrile Neutropenia 12/2022
1	Neutropenia 12/2022
1	Invasive Fungal Infections 10/2022
1	Bronchiolitis Obliterans Syndrome 10/2022
1	Acute Promyelocytic Leukemia 01/2021
1	Inflammation (Inflammations) 01/2021
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2019
1	Fatigue 01/2019
1	Dysbiosis 10/2018
1	Insulin Resistance 10/2018
1	Respiratory Insufficiency (Respiratory Failure) 01/2018
1	Infections 01/2018
1	Sepsis (Septicemia) 01/2018
1	Hyperbilirubinemia 10/2017

Drug/Important Bio-Agent (IBA)

37	venetoclaxIBA 01/2024 - 10/2016
21	Azacitidine (5 Azacytidine)FDA Link 12/2023 - 04/2013
8	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2022 - 11/2010
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2011
5	enasidenibIBA 01/2021 - 10/2017
5	glasdegibIBA 10/2020 - 01/2018
4	Decitabine FDA Link 01/2021 - 01/2018
3	ivosidenibIBA 01/2021 - 01/2020
3	Amino Acids FDA Link 11/2020 - 11/2018
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2020 - 10/2017
3	Daunorubicin (Cerubidine)FDA LinkGeneric 11/2019 - 01/2018
3	Lenalidomide (CC 5013)FDA Link 01/2019 - 04/2013
2	Monoclonal AntibodiesIBA 01/2023 - 01/2021
2	EnzymesIBA 01/2021 - 03/2015
2	CytokinesIBA 01/2021 - 01/2016
2	fms-Like Tyrosine Kinase 3IBA 10/2020 - 10/2016
2	isocitric acid (isocitrate)IBA 04/2020 - 01/2019
2	midostaurinIBA 11/2019 - 12/2017
2	parthenolideIBA 11/2016 - 10/2016
2	Oxidoreductases (Dehydrogenase)IBA 03/2015 - 03/2014
2	Tyrosine Kinase InhibitorsIBA 03/2015 - 09/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2015 - 05/2013
2	AldehydesIBA 01/2015 - 03/2014
2	Phosphotransferases (Kinase)IBA 09/2014 - 05/2013
1	cobimetinibIBA 01/2024
1	CalciumIBA 10/2023
1	navitoclaxIBA 09/2023
1	brexucabtagene autoleucelIBA 01/2023
1	asciminibIBA 01/2023
1	magrolimabIBA 01/2023
1	recombinant-rywn asparaginase erwinia chrysanthemiIBA 01/2023
1	vorasidenibIBA 01/2023
1	RG7388IBA 01/2023
1	molibresibIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	atezolizumabIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Lipase (Acid Lipase)FDA Link 01/2021
1	DCLL9718SIBA 01/2021
1	C-Type Lectins (C-Type Lectin)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2020
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 12/2020
1	Niacinamide (Nicotinamide)FDA LinkGeneric 11/2020
1	AnthracyclinesIBA 10/2020
1	RNA (Ribonucleic Acid)IBA 12/2019
1	Core Binding Factors (Core-Binding Factor)IBA 11/2019
1	Gemtuzumab (Mylotarg)FDA Link 11/2019
1	Arginine (L-Arginine)FDA Link 01/2019
1	Electron Transport Complex II (Succinate-Coenzyme Q Reductase)IBA 01/2019
1	Cysteine (L-Cysteine)FDA Link 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 10/2018
1	Glucose (Dextrose)FDA LinkGeneric 10/2018
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 12/2017
1	Interleukin-1 (Interleukin 1)IBA 01/2017

Therapy/Procedure

28	Therapeutics 01/2024 - 05/2010
24	Drug Therapy (Chemotherapy) 01/2024 - 05/2010
4	Induction Chemotherapy 12/2021 - 01/2018
2	Salvage Therapy 09/2023 - 01/2023
2	Transplantation 01/2023 - 10/2022
2	Hematopoietic Stem Cell Transplantation 01/2023 - 10/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023
1	Immunotherapy 01/2023
1	Blood Transfusion (Blood Transfusions) 01/2021
1	Stem Cell Transplantation 10/2020
1	Remission Induction 10/2020
1	Heterologous Transplantation (Xenotransplantation) 01/2019